Exact Sciences CorporationUnderwriting Agreement • February 27th, 2020 • Exact Sciences Corp • Services-commercial physical & biological research • New York
Exact Sciences Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) $1,000,000,000 aggregate principal amount of the Company’s 0.3750% Convertible Senior Notes due 2028 (the “Convertible Senior Notes”). The $1,000,000,000 aggregate principal amount of the Convertible Senior Notes to be sold by the Company are called the “Initial Securities.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional $150,000,000 aggregate principal amount of its Convertible Senior Notes as provided in Section 2. The additional $150,000,000 aggregate principal amount of Convertible Senior Notes to be sold by the Company pursuant to such option are called the “Option Securities.” The Initial Securities and, if and to the extent such option is exercised, the Option Securities are collectively called the “Securities.” The Securities are to be issued pursuant to an indentur
